Published in Cell Microbiol on February 27, 2009
Autophagy in protists. Autophagy (2011) 1.29
Toxoplasma gondii activates hypoxia-inducible factor (HIF) by stabilizing the HIF-1alpha subunit via type I activin-like receptor kinase receptor signaling. J Biol Chem (2010) 0.98
The bacterial and cellular determinants controlling the recruitment of mTOR to the Salmonella-containing vacuole. Biol Open (2012) 0.95
Coordinate control of host centrosome position, organelle distribution, and migratory response by Toxoplasma gondii via host mTORC2. J Biol Chem (2010) 0.87
Altered regulation of Akt signaling with murine cerebral malaria, effects on long-term neuro-cognitive function, restoration with lithium treatment. PLoS One (2012) 0.79
Toxoplasma Effectors Targeting Host Signaling and Transcription. Clin Microbiol Rev (2017) 0.75
Microfilariae of Brugia malayi Inhibit the mTOR Pathway and Induce Autophagy in Human Dendritic Cells. Infect Immun (2016) 0.75
The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science (2008) 14.08
Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis. Cell (2005) 7.75
Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation. Proc Natl Acad Sci U S A (2008) 6.84
Ribosomal protein S6 phosphorylation: from protein synthesis to cell size. Trends Biochem Sci (2006) 5.11
Toxoplasma co-opts host gene expression by injection of a polymorphic kinase homologue. Nature (2006) 4.50
Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer. Nat Med (2005) 4.44
Ribosomal protein S6 phosphorylation is a determinant of cell size and glucose homeostasis. Genes Dev (2005) 4.41
Targeting the PI3K/Akt/mTOR pathway: effective combinations and clinical considerations. Drug Resist Updat (2007) 3.78
Identification of a conserved motif required for mTOR signaling. Curr Biol (2002) 3.78
Rheb activates mTOR by antagonizing its endogenous inhibitor, FKBP38. Science (2007) 3.75
mTOR is essential for growth and proliferation in early mouse embryos and embryonic stem cells. Mol Cell Biol (2004) 3.72
Hypoinsulinaemia, glucose intolerance and diminished beta-cell size in S6K1-deficient mice. Nature (2001) 3.65
TSC2: filling the GAP in the mTOR signaling pathway. Trends Biochem Sci (2004) 3.56
Protein phosphatase 2A interacts with the 70-kDa S6 kinase and is activated by inhibition of FKBP12-rapamycinassociated protein. Proc Natl Acad Sci U S A (1999) 3.49
Differential impact of mammalian target of rapamycin inhibition on CD4+CD25+Foxp3+ regulatory T cells compared with conventional CD4+ T cells. Blood (2007) 3.27
Amino acids activate mTOR complex 1 via Ca2+/CaM signaling to hVps34. Cell Metab (2008) 2.96
Atrophy of S6K1(-/-) skeletal muscle cells reveals distinct mTOR effectors for cell cycle and size control. Nat Cell Biol (2005) 2.80
Toxoplasma gondii sequesters lysosomes from mammalian hosts in the vacuolar space. Cell (2006) 2.79
mTOR, translational control and human disease. Semin Cell Dev Biol (2004) 2.77
Distinct signaling events downstream of mTOR cooperate to mediate the effects of amino acids and insulin on initiation factor 4E-binding proteins. Mol Cell Biol (2005) 2.47
Determinants of rapamycin sensitivity in breast cancer cells. Clin Cancer Res (2004) 2.44
Multiple mechanisms control phosphorylation of PHAS-I in five (S/T)P sites that govern translational repression. Mol Cell Biol (2000) 2.35
eIF4GI links nutrient sensing by mTOR to cell proliferation and inhibition of autophagy. J Cell Biol (2008) 2.26
Association of host cell endoplasmic reticulum and mitochondria with the Toxoplasma gondii parasitophorous vacuole membrane: a high affinity interaction. J Cell Sci (1997) 2.16
Role of S6 phosphorylation and S6 kinase in cell growth. Prog Nucleic Acid Res Mol Biol (2001) 2.15
Regulation of mTOR by phosphatidic acid? Cancer Res (2007) 2.05
Phospholipase D1 is an effector of Rheb in the mTOR pathway. Proc Natl Acad Sci U S A (2008) 1.97
Mammalian target of rapamycin-dependent phosphorylation of PHAS-I in four (S/T)P sites detected by phospho-specific antibodies. J Biol Chem (2000) 1.83
mTOR signaling: implications for cancer and anticancer therapy. Br J Cancer (2006) 1.72
Rapamycin inhibits F-actin reorganization and phosphorylation of focal adhesion proteins. Oncogene (2008) 1.64
Microneme proteins: structural and functional requirements to promote adhesion and invasion by the apicomplexan parasite Toxoplasma gondii. Int J Parasitol (2001) 1.60
Up-regulation of acetyl-CoA carboxylase alpha and fatty acid synthase by human epidermal growth factor receptor 2 at the translational level in breast cancer cells. J Biol Chem (2007) 1.56
Host cells: mobilizable lipid resources for the intracellular parasite Toxoplasma gondii. J Cell Sci (2002) 1.54
Assembly of 48S translation initiation complexes from purified components with mRNAs that have some base pairing within their 5' untranslated regions. Mol Cell Biol (2003) 1.46
S6 kinase inactivation impairs growth and translational target phosphorylation in muscle cells maintaining proper regulation of protein turnover. Am J Physiol Cell Physiol (2007) 1.44
Translational homeostasis: eukaryotic translation initiation factor 4E control of 4E-binding protein 1 and p70 S6 kinase activities. Mol Cell Biol (1999) 1.44
Host cell autophagy is induced by Toxoplasma gondii and contributes to parasite growth. J Biol Chem (2008) 1.34
Tuberous sclerosis complex proteins 1 and 2 control serum-dependent translation in a TOP-dependent and -independent manner. Mol Cell Biol (2007) 1.23
Activation of protein synthesis in cardiomyocytes by the hypertrophic agent phenylephrine requires the activation of ERK and involves phosphorylation of tuberous sclerosis complex 2 (TSC2). Biochem J (2005) 1.21
New targets for therapy in breast cancer: mammalian target of rapamycin (mTOR) antagonists. Breast Cancer Res (2004) 1.20
Mammalian target of rapamycin is the key effector of phosphatidylinositol-3-OH-initiated proliferative signals in the thyroid follicular epithelium. Cancer Res (2008) 1.20
Modulation of the host cell proteome by the intracellular apicomplexan parasite Toxoplasma gondii. Infect Immun (2007) 1.18
Predicted mechanisms of resistance to mTOR inhibitors. Br J Cancer (2006) 1.17
Infection with Toxoplasma gondii results in dysregulation of the host cell cycle. Cell Microbiol (2008) 1.14
PLD2 forms a functional complex with mTOR/raptor to transduce mitogenic signals. Cell Signal (2006) 1.11
Secretion of proteins into host cells by Apicomplexan parasites. Traffic (2008) 1.10
Toxoplasma gondii exploits UHRF1 and induces host cell cycle arrest at G2 to enable its proliferation. Cell Microbiol (2007) 1.09
The Toxoplasma gondii parasitophorous vacuole membrane: transactions across the border. J Eukaryot Microbiol (2007) 1.09
Detection of a novel parasite kinase activity at the Toxoplasma gondii parasitophorous vacuole membrane capable of phosphorylating host IkappaBalpha. Cell Microbiol (2005) 1.08
Control of macromolecular synthesis in proliferating and resting Syrian hamster cells in monolayer culture. II. Ribosome complement in resting and early G1 cells. J Cell Physiol (1971) 1.07
Rapamycin-FKBP12 blocks proliferation, induces differentiation, and inhibits cdc2 kinase activity in a myogenic cell line. J Biol Chem (1993) 1.07
Initiation and termination of NF-kappaB signaling by the intracellular protozoan parasite Toxoplasma gondii. J Cell Sci (2005) 1.04
Control of PHAS-I phosphorylation in 3T3-L1 adipocytes: effects of inhibiting protein phosphatases and the p70S6K signalling pathway. Diabetologia (1997) 1.03
Unique, highly proliferative growth phenotype expressed by embryonic and neointimal smooth muscle cells is driven by constitutive Akt, mTOR, and p70S6K signaling and is actively repressed by PTEN. Circulation (2004) 1.02
AKT-independent phosphorylation of TSC2 and activation of mTOR and ribosomal protein S6 kinase signaling by prostaglandin F2alpha. J Biol Chem (2006) 0.99
Toxoplasma gondii actively remodels the microtubule network in host cells. Microbes Infect (2008) 0.99
Uncoupling p70(s6) kinase activation and proliferation: rapamycin-resistant proliferation of human CD8(+) T lymphocytes. J Immunol (2001) 0.98
Ribosomal proteins are synthesized preferentially in cells commencing growth. J Cell Physiol (1982) 0.94
Regulation of protein synthesis by leucine starvation involves distinct mechanisms in mouse C2C12 myoblasts and myotubes. J Nutr (2006) 0.94
Ribosomal protein S6 is a selective mediator of TRAIL-apoptotic signaling. Oncogene (2008) 0.86
Toxoplasma-induced autophagy: a window into nutritional futile cycles in mammalian cells? Autophagy (2009) 0.81
Microsporidiosis: current status. Curr Opin Infect Dis (2006) 2.81
Toxoplasma gondii: the model apicomplexan. Int J Parasitol (2004) 2.10
Blastocystis: to treat or not to treat... Clin Infect Dis (2011) 2.01
Caveolin-1 null mice develop cardiac hypertrophy with hyperactivation of p42/44 MAP kinase in cardiac fibroblasts. Am J Physiol Cell Physiol (2002) 1.86
The adipocyte as an important target cell for Trypanosoma cruzi infection. J Biol Chem (2005) 1.82
Microsporidiosis: not just in AIDS patients. Curr Opin Infect Dis (2011) 1.77
Genomic survey of the non-cultivatable opportunistic human pathogen, Enterocytozoon bieneusi. PLoS Pathog (2009) 1.73
A novel mouse model of inflammatory bowel disease links mammalian target of rapamycin-dependent hyperproliferation of colonic epithelium to inflammation-associated tumorigenesis. Am J Pathol (2009) 1.70
Post-translational modifications to Toxoplasma gondii alpha- and beta-tubulins include novel C-terminal methylation. J Proteome Res (2010) 1.64
Perspectives on Trypanosoma cruzi-induced heart disease (Chagas disease). Prog Cardiovasc Dis (2009) 1.60
Fatal myositis due to the microsporidian Brachiola algerae, a mosquito pathogen. N Engl J Med (2004) 1.51
Mechanisms of Trypanosoma cruzi persistence in Chagas disease. Cell Microbiol (2012) 1.45
Caveolin-1/3 double-knockout mice are viable, but lack both muscle and non-muscle caveolae, and develop a severe cardiomyopathic phenotype. Am J Pathol (2002) 1.43
Type II Toxoplasma gondii KU80 knockout strains enable functional analysis of genes required for cyst development and latent infection. Eukaryot Cell (2011) 1.40
NF-kappa B1 p50 is required for BLyS attenuation of apoptosis but dispensable for processing of NF-kappa B2 p100 to p52 in quiescent mature B cells. J Immunol (2003) 1.38
Control of Toxoplasma reactivation by rescue of dysfunctional CD8+ T-cell response via PD-1-PDL-1 blockade. Proc Natl Acad Sci U S A (2011) 1.34
Host cell autophagy is induced by Toxoplasma gondii and contributes to parasite growth. J Biol Chem (2008) 1.34
Chagas disease has now gone global. PLoS Negl Trop Dis (2011) 1.34
Caveolin-1 null (-/-) mice show dramatic reductions in life span. Biochemistry (2003) 1.31
The reduced genome of the parasitic microsporidian Enterocytozoon bieneusi lacks genes for core carbon metabolism. Genome Biol Evol (2010) 1.30
The microsporidian polar tube: a highly specialised invasion organelle. Int J Parasitol (2005) 1.28
Cardioprotective effects of verapamil on myocardial structure and function in a murine model of chronic Trypanosoma cruzi infection (Brazil Strain): an echocardiographic study. Int J Parasitol (2002) 1.27
Current understanding of immunity to Trypanosoma cruzi infection and pathogenesis of Chagas disease. Semin Immunopathol (2012) 1.26
Thromboxane A2 is a key regulator of pathogenesis during Trypanosoma cruzi infection. J Exp Med (2007) 1.21
Microarray analysis of changes in gene expression in a murine model of chronic chagasic cardiomyopathy. Parasitol Res (2003) 1.19
Trypanosoma cruzi utilizes the host low density lipoprotein receptor in invasion. PLoS Negl Trop Dis (2011) 1.17
Induction of a rapid and strong antigen-specific intraepithelial lymphocyte response during oral Encephalitozoon cuniculi infection. J Immunol (2004) 1.17
Parasitic diseases of the heart. Front Biosci (2004) 1.17
Cognitive dysfunction in mice infected with Plasmodium berghei strain ANKA. J Infect Dis (2008) 1.16
Patterns of genome evolution among the microsporidian parasites Encephalitozoon cuniculi, Antonospora locustae and Enterocytozoon bieneusi. PLoS One (2007) 1.16
Antibody efficacy in murine pulmonary Cryptococcus neoformans infection: a role for nitric oxide. J Immunol (2002) 1.16
Genome sequence surveys of Brachiola algerae and Edhazardia aedis reveal microsporidia with low gene densities. BMC Genomics (2008) 1.16
Bone marrow cell therapy ameliorates and reverses chagasic cardiomyopathy in a mouse model. J Infect Dis (2008) 1.16
Role of endothelin 1 in the pathogenesis of chronic chagasic heart disease. Infect Immun (2005) 1.15
Chagas' disease and AIDS. Kinetoplastid Biol Dis (2004) 1.12
Toxoplasma: the next 100years. Microbes Infect (2008) 1.12
Trypanosoma cruzi infection of cultured adipocytes results in an inflammatory phenotype. Obesity (Silver Spring) (2008) 1.12
Toxoplasmosis. Handb Clin Neurol (2013) 1.11
A1 is a growth-permissive antiapoptotic factor mediating postactivation survival in T cells. Blood (2002) 1.10
Acquired infection with Toxoplasma gondii in adult mice results in sensorimotor deficits but normal cognitive behavior despite widespread brain pathology. Microbes Infect (2010) 1.09
Response of adipose tissue to early infection with Trypanosoma cruzi (Brazil strain). J Infect Dis (2012) 1.09
Trypanosoma cruzi infection activates extracellular signal-regulated kinase in cultured endothelial and smooth muscle cells. Infect Immun (2004) 1.08
Computational analysis and experimental validation of gene predictions in Toxoplasma gondii. PLoS One (2008) 1.08
Molecular diagnostic tests for microsporidia. Interdiscip Perspect Infect Dis (2009) 1.08
Gain and loss of multiple functionally related, horizontally transferred genes in the reduced genomes of two microsporidian parasites. Proc Natl Acad Sci U S A (2012) 1.08
Activation of transcription factors AP-1 and NF-kappa B in murine Chagasic myocarditis. Infect Immun (2003) 1.07
Endothelin in a murine model of cerebral malaria. Exp Biol Med (Maywood) (2006) 1.06
Cerebral malaria: we have come a long way. Am J Pathol (2012) 1.04
ApiAP2 transcription factor restricts development of the Toxoplasma tissue cyst. Proc Natl Acad Sci U S A (2013) 1.04
Novel synthetic polyamines are effective in the treatment of experimental microsporidiosis, an opportunistic AIDS-associated infection. Antimicrob Agents Chemother (2002) 1.03
Identification and characterisation of a regulatory region in the Toxoplasma gondii hsp70 genomic locus. Int J Parasitol (2004) 1.03
Chagas heart disease: report on recent developments. Cardiol Rev (2012) 1.02
IFN-gamma-producing dendritic cells are important for priming of gut intraepithelial lymphocyte response against intracellular parasitic infection. J Immunol (2007) 1.02
Characterization of Mycobacterium montefiorense sp. nov., a novel pathogenic Mycobacterium from moray eels that is related to Mycobacterium triplex. J Clin Microbiol (2003) 1.01
Role of protein kinase A in Trypanosoma cruzi. Infect Immun (2008) 1.00
Microarray technology in the investigation of diseases of myocardium with special reference to infection. Front Biosci (2006) 1.00
Comprehensive proteomic analysis of membrane proteins in Toxoplasma gondii. Mol Cell Proteomics (2010) 1.00
Persistent cognitive and motor deficits after successful antimalarial treatment in murine cerebral malaria. Microbes Infect (2010) 1.00
Cardioprotective effects of phosphoramidon on myocardial structure and function in murine Chagas' disease. Int J Parasitol (2002) 0.99
Cerebral malaria: a vasculopathy. Am J Pathol (2010) 0.99
Cyclic nucleotide kinases and tachyzoite-bradyzoite transition in Toxoplasma gondii. Int J Parasitol (2005) 0.99
Identification of a new spore wall protein from Encephalitozoon cuniculi. Infect Immun (2006) 0.98
Crucial role of the central leptin receptor in murine Trypanosoma cruzi (Brazil strain) infection. J Infect Dis (2010) 0.98
Significance of inducible nitric oxide synthase in acute myocarditis caused by Trypanosoma cruzi (Tulahuen strain). Int J Parasitol (2002) 0.98
Alterations in myocardial gene expression associated with experimental Trypanosoma cruzi infection. Genomics (2008) 0.97
Aspirin treatment of mice infected with Trypanosoma cruzi and implications for the pathogenesis of Chagas disease. PLoS One (2011) 0.97
Role of SOCS2 in modulating heart damage and function in a murine model of acute Chagas disease. Am J Pathol (2012) 0.96
EPIC-DB: a proteomics database for studying Apicomplexan organisms. BMC Genomics (2009) 0.96
Mitochondrial-type hsp70 genes of the amitochondriate protists, Giardia intestinalis, Entamoeba histolytica and two microsporidians. Parasitol Int (2002) 0.95
Glycosylation of the major polar tube protein of Encephalitozoon hellem, a microsporidian parasite that infects humans. Infect Immun (2004) 0.95
Cyclin and caveolin expression in an acute model of murine Chagasic myocarditis. Cell Cycle (2006) 0.95
Effects of early and late verapamil administration on the development of cardiomyopathy in experimental chronic Trypanosoma cruzi (Brazil strain) infection. Parasitol Res (2004) 0.94
A review of the development of two types of human skeletal muscle infections from microsporidia associated with pathology in invertebrates and cold-blooded vertebrates. Folia Parasitol (Praha) (2005) 0.94
3-Methyladenine blocks Toxoplasma gondii division prior to centrosome replication. Mol Biochem Parasitol (2010) 0.94
Investigations into microsporidian methionine aminopeptidase type 2: a therapeutic target for microsporidiosis. Folia Parasitol (Praha) (2005) 0.94
Trypanosoma cruzi infection induces proliferation of vascular smooth muscle cells. Infect Immun (2006) 0.94
Acquisition of an animal gene by microsporidian intracellular parasites. Curr Biol (2011) 0.94
Microarray analysis of IFN-gamma response genes in astrocytes. J Neuroimmunol (2006) 0.93
STAT3 in epithelial cells regulates inflammation and tumor progression to malignant state in colon. Neoplasia (2013) 0.93
Bioactive lipids in Trypanosoma cruzi infection. Adv Parasitol (2011) 0.93
Curcumin treatment provides protection against Trypanosoma cruzi infection. Parasitol Res (2012) 0.93
The histone code of Toxoplasma gondii comprises conserved and unique posttranslational modifications. MBio (2013) 0.93
Coinfection with Heligmosomoides polygyrus fails to establish CD8+ T-cell immunity against Toxoplasma gondii. Infect Immun (2008) 0.92
Brachiola algerae spore membrane systems, their activity during extrusion, and a new structural entity, the multilayered interlaced network, associated with the polar tube and the sporoplasm. J Eukaryot Microbiol (2002) 0.92
Externally triggered egress is the major fate of Toxoplasma gondii during acute infection. J Immunol (2009) 0.92
Trypanosoma cruzi infection induced changes in the innervation, structure and function of the murine bladder. J Urol (2005) 0.92
Perspectives on the Trypanosoma cruzi-host cell receptor interactions. Parasitol Res (2009) 0.92
Extremely reduced levels of heterozygosity in the vertebrate pathogen Encephalitozoon cuniculi. Eukaryot Cell (2013) 0.91
Nonprotein based enrichment method to analyze peptide cross-linking in protein complexes. Anal Chem (2009) 0.91
Complete genome sequences from three genetically distinct strains reveal high intraspecies genetic diversity in the microsporidian Encephalitozoon cuniculi. Eukaryot Cell (2013) 0.90
Analysis of the glycoproteome of Toxoplasma gondii using lectin affinity chromatography and tandem mass spectrometry. Microbes Infect (2011) 0.90
Deficiency in the anti-apoptotic protein A1-a results in a diminished acute inflammatory response. J Immunol (2002) 0.90
Alterations in glucose homeostasis in a murine model of Chagas disease. Am J Pathol (2013) 0.89
Risedronate in the treatment of Murine Chagas' disease. Parasitol Res (2005) 0.89
Molecular cloning and characterization of the protein kinase A regulatory subunit of Trypanosoma cruzi. Mol Biochem Parasitol (2006) 0.89
A magnetic resonance imaging study of intestinal dilation in Trypanosoma cruzi-infected mice deficient in nitric oxide synthase. Am J Trop Med Hyg (2008) 0.88